Neoplasm by Site — Trials

Neoplasm by Site — Trials · CancerIndex

Clinical trials

Registered studies

92,566 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 8,791 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02257736	An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)	active not recruiting	Phase 3	982	Aragon Pharmaceuticals, Inc.INDUSTRY	16	Sep 28, 2026	clinicaltrials
NCT02489318	A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC(TITAN)	active not recruiting	Phase 3	1,052	Aragon Pharmaceuticals, Inc.